Arthurian Life Sciences

Arthurian Life Sciences Ltd was established by Europe's leading biotech entrepreneur Professor Sir Chris Evans OBE to act as General Partner of the Wales Life Sciences Investment Fund, a £100 million fund and key part of the Welsh Government's Life Sciences initiative. The Fund will invest in Life Sciences and related medical, pharmaceutical and healthcare companies currently based in Wales, and also in companies from across the UK, Europe and the rest of the world, where such investment will bring meaningful developmental and economic benefit to Wales. The Fund will make initial investments of between £500,000 and £5,000,000, and will preserve capital to provide follow-on investments. Larger investments may be considered. Arthurian will spread investments by risk, sub-sector, age or funding requirement and will consider companies of all sizes, both start-ups and mature companies, and will do both early & late stage investments. The Fund will primarily focus on a small number of companies, encourage, support, grow and build up most promising existing companies and new start-ups, attract non-Welsh companies and entrepreneurs to Wales, attract corporate venture spin-outs to Wales, encourage and back international partnerships, focus across the full spectrum of Life Sciences sector – healthcare, diagnostics, medical technology, biotech and pharmaceuticals, back smart and experienced people, attract international co-investors, and generate significant amounts of positive press coverage for Wales. Investments can be made immediately and applications together with business cases should be directed to enquiry@arthurianlifesciences.co.uk. The Arthurian team has been specially assembled to make a major difference and generate a real excitement within Welsh Life Sciences both domestically and internationally.